High chance to overcome the non-responder status to hepatitis B vaccine after a further full vaccination course: results from the extended study on healthcare students and workers in Florence, Italy

References

• World Health Organization (WHO). Global hepatitis report 2017. WHO web-site. [accessed 2019 Apr 10]. https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/.
   Google Scholar
• Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med PMID: 8988900. 1997;336:196–204. doi:10.1056/NEJM199701163360307.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Expanded programme on immunization global advisory group. Weekly Epidemiol Rec 1992;3:11–16.
   Google Scholar
• Van Damme P, Kane M, Meheus A. Integration of hepatitis B vaccination into national immunisation programmes. Viral hepatitis prevention board. BMJ. 1997;314:1033–36. PMID: 9112852. doi:10.1136/bmj.314.7086.1033.
   PubMed Web of Science ®Google Scholar
• Boccalini S, Pellegrino E, Tiscione E, Pesavento G, Bechini A, Levi M, Rapi S, Mercurio S, Mannelli F, Peruzzi M, et al. Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination. Hum Vaccin Immunother. 2013;9(3):636–41. PMID: 23354158. doi:10.4161/hv.23259.
   PubMed Web of Science ®Google Scholar
• Stroffolini T, Mele A, Tosti ME, Gallo G, Balocchini E, Ragni P, Santonastasi F, Marzolini A, Ciccozzi M, Moiraghi A. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol. 2000;33:980–85. PMID: 11131462.
   PubMed Web of Science ®Google Scholar
• Rice BD, Tomkins SE, Ncube FM. Sharp truth: health care workers remain at risk of bloodborne infection. Occup Med (Lond) PMID: 25663385. 2015;65(3):210–14. doi:10.1093/occmed/kqu206.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Global health sector strategy on viral hepatitis 2016–2021. 2016. WHO web-site. [accessed 2019 Apr 10]. http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pdf?ua.
   Google Scholar
• Centers for disease control and prevention. Immunization of health-care personnel: recommendations of the advisory committee on immunization practices (ACIP). MMWR. 2011;60(RR–7):1–45. PMID: 22108587. Available at https://www.cdc.gov/mmwr/pdf/rr/rr6007.pdf
   Google Scholar
• Law n. 165, 27 May 1991. Obbligatorietà della vaccinazione contro l’epatite virale B. Gazz. Uff., n. 127, 1°giugno 1991.
   Google Scholar
• Italian Ministry of Health. Ministerial Circular n.20, 4 October 1991. Disposizioni relative all’applicazione della legge 27 maggio 1991, n.165. Gazz.Uff. n. 251, 25 ottobre 1991.
   Google Scholar
• Bonanni P, Bonaccorsi G. Vaccination against hepatitis B in health care workers. Vaccine PMID:11257366. 2001;19(17–19):2389–94. doi:10.1016/S0264-410X(00)00460-6.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. In: Hamborsky J, Kroger A, Wolfe S, editors. Chapter 10, Hepatitis B. 13th. Washington (DC): Public Health Foundation; 2015. p. 149–174. Available at. https://www.cdc.gov/vaccines/pubs/pinkbook/hepb.html
   Google Scholar
• Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J PrevMed PMID:9651632. 1998;15:1–8. doi:10.1016/S0749-3797(98)00003-8.
   PubMed Web of Science ®Google Scholar
• Italian Ministry of Health. Piano Nazionale Prevenzione Vaccinale (PNPV) 2017–2019. Gazz. Uff. n. 41,l 18 febbraio 2017. Available at: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf
   Google Scholar
• Bini C, Grazzini M, Chellini M, Mucci N, Arcangeli G, Tiscione E, Bonanni P. Is hepatitis B vaccination performed at infant and adolescent age able to provide long-termimmunological memory? An observational study on healthcare students and workers in Florence, Italy. Hum Vaccin Immunother PMID: 29106317. 2018;14(2):450–55. doi:10.1080/21645515.2017.1398297.
   PubMed Web of Science ®Google Scholar
• Law n. 81, 9 April 2008. Testo Unico sulla salute e sicurezza sul lavoro. Gazz. Uff. n. 101, 30 aprile 2008.
   Google Scholar
• Westmoreland D, Player V, Heap DC, Hammond A. Immunization against hepatitis B–what can we expect? Results of a survey of antibody response to immunization in persons ‘at risk’ of occupational exposure to hepatitis B. Epidemiol Infect PMID:2140795. 1990;104(3):499–509. doi:10.1017/S0950268800047506.
   PubMed Web of Science ®Google Scholar
• Schillie S, Vellozzi C, Reingold A. Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep PMID: 29939980. 2018;67(1):1–31. doi:10.15585/mmwr.rr6701a1.
   PubMed Web of Science ®Google Scholar
• Centers for disease control and prevention. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR. 2013;62(RR–10):1–19. [accessed 2019 Apr 10]. https://www.cdc.gov/mmwr/pdf/rr/rr6210.pdf.
   PubMedGoogle Scholar
• Wang ZZ, Gao YH, Lu W, Jin CD, Zeng Y, Yan L, Ding F, Li T, Li XE, Zhuang H. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China. Hum Vaccin Immunother PMID: 27874311. 2017;13(4):909–15. doi:10.1080/21645515.2016.1250990.
   PubMed Web of Science ®Google Scholar
• Bagheri-Jamebozorgi M, Keshavarz J, Nemati M, Mohammadi-Hossainabad S, Rezayati MT, Nejad-Ghaderi M, Jamalizadeh A, Shokri F, Jafarzadeh A. The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy. Hum Vaccin Immunother PMID: 25483689. 2014;10(12):3731–36. doi:10.4161/hv.34393.
   PubMed Web of Science ®Google Scholar
• Dini G, Toletone A, Barberis I, Debarbieri N, Massa E, Paganino C, Bersi F, Montecucco A, Alicino C, Durando P. Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: a cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy. Hum Vaccin Immunother PMID: 27925503. 2017;13(2):440–44. doi:10.1080/21645515.2017.1264788.
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Mariano A, Romano L, D’Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 2005;366(9494):1379–84. PMID: 16226616. doi:10.1016/S0140-6736(05)67568-X.
   PubMed Web of Science ®Google Scholar
• Zanetti A, Desole MG, Romanò L, d’Alessandro A, Conversano M, Ferrera G, Panico MG, Tomasi A, Zoppi G, Zuliani M, et al. Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: an open-label, controlled, multicentre trial in Italy. Vaccine PMID: 28624307. 2017;35:4034–40. doi:10.1016/j.vaccine.2017.05.047.
   PubMed Web of Science ®Google Scholar
• Zuckerman JN. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol PMID: 16372285. 2006;78(2):169–77. doi:10.1002/jmv.20524.
   PubMed Web of Science ®Google Scholar
• Clemens R, Sänger R, Kruppenbacher J, Hobel W, Stanbury W, Bock H, Jilg W. Booster immunization of low-and non-responders after a standard three dose hepatitis B vaccine schedule—results of a post-marketing surveillance. Vaccine. 1997;15(4):349–52. PMID: 9141203.
   PubMed Web of Science ®Google Scholar
• Petek D, Kamnik-Jug K. Motivators and barriers to vaccination of health professionals against seasonal influenza in primary healthcare. BMC Health Serv Res. 2018;18(1):853. doi:10.1186/s12913-018-3659-8.
   PubMedGoogle Scholar
• Lorenc T, Marshall D, Wright K, Sutcliffe K, Sowden A. Seasonal influenza vaccination of healthcare workers: systematic review of qualitative evidence. BMC Health Serv Res. 2017;17(1):732. doi:10.1186/s12913-017-2703-4.
   PubMed Web of Science ®Google Scholar
• Topuridze M, Butsashvili M, Kamkamidze G, Kajaia M, Morse D, McNutt LA. Barriers to hepatitis B vaccine coverage among healthcare workers in the Republic of Georgia: an international perspective. Infect Control Hosp Epidemiol. 2010 Feb;31(2):158–64. doi:10.1086/649795.
   PubMed Web of Science ®Google Scholar
• Kisic-Tepavcevic D, Kanazir M, Gazibara T, Maric G, Makismovic N, Loncarevic G, Pekmezovic T. Predictors of hepatitis B vaccination status in healthcare workers in Belgrade, Serbia, December 2015. Euro Surveill. 2017;22:30515. doi:10.2807/1560-7917.
   PubMedGoogle Scholar
• Maltezou HC, Theodoridou K, Ledda C, Rapisarda V, Theodoridou M. Vaccination of healthcare workers: is mandatory vaccination needed? Expert Rev Vaccines. 2019 Jan;18(1):5–13. doi:10.1080/14760584.2019.1552141.
   PubMed Web of Science ®Google Scholar
• Rolnick SJ, Parker ED, Nordin JD, Hedblom BD, Wei F, Kerby T, Jackson JM, Crain AL, Euler G. Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors? Vaccine. 2013;31:3928–35. doi:10.1016/j.vaccine.2013.06.041.
   PubMed Web of Science ®Google Scholar
• Chen DS. Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J Hepatol. 2009;50:805–16. doi:10.1016/j.jhep.2009.01.002.
   PubMed Web of Science ®Google Scholar
• Italian integrated surveillance system for acute viral hepatitis SEIEVA [Internet]. [accessed 2019 Apr 10]. http://www.iss.it/seieva/.
   Google Scholar